Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

NCT03419234 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

223

Enrollment

NETWORK

Sponsor class

Conditions

Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma in the Soft Tissue
Prostate Carcinoma Metastatic in the Bone
Stage IV Prostate Adenocarcinoma AJCC v7

Interventions

DRUG: Abiraterone Acetate
DRUG: Androgen deprivation therapy
DRUG: Cabazitaxel
DRUG: Prednisone

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]